JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program

HYOGO, Japan--(BUSINESS WIRE)--JCR announced that is has achieved a key research milestone in one of its collaborative programs with Alexion, AstraZeneca Rare Disease. ...